DrugPatentWatch Database Preview
Drugs in Development Information for Tannic acid
» See Plans and Pricing
What is the development status for investigational drug Tannic acid?
Tannic acid is an investigational drug.
There have been 3 clinical trials for Tannic acid.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2007.
The most common disease conditions in clinical trials are Hemorrhoids, Malabsorption Syndromes, and Gastroesophageal Reflux. The leading clinical trial sponsors are Universidade do Porto, Hospital Infantil Cândido Fontoura, and [disabled in preview].
Summary for Tannic acid
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,053 |
| WIPO Patent Applications | 986 |
| Japanese Patent Applications | 896 |
| Clinical Trial Progress | Phase 3 (2007-08-01) |
| Vendors | 0 |
Recent Clinical Trials for Tannic acid
| Title | Sponsor | Phase |
|---|---|---|
| Polidocanol Boam VS Band Ligation VS Artery Ligation in Hemorrhoidal Disease | Universidade do Porto | Phase 2/Phase 3 |
| Polidocanol Foam Versus Rubber Band Ligation in the Treatment of Hemorrhoidal Disease | Universidade do Porto | Phase 2 |
| Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in Children | Hospital Infantil Cândido Fontoura | Phase 3 |
Clinical Trial Summary for Tannic acid
Top disease conditions for Tannic acid
Top clinical trial sponsors for Tannic acid
US Patents for Tannic acid
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
